User contributions for Aidan

From IDWiki
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

7 June 2023

6 June 2023

5 June 2023

19 May 2023

18 May 2023

17 May 2023

15 May 2023

11 May 2023

10 May 2023

9 May 2023

8 May 2023

  • 16:5416:54, 8 May 2023 diff hist 0 m BrevundimonasNo edit summary current Tag: Visual edit
  • 15:3815:38, 8 May 2023 diff hist +446 N BrevundimonasCreated page with "{{DISPLAYTITLE:''Brevundimonas''}} * Genus of afermentative Stain::gram-negative Shape::bacillus == Further Reading == * ''Brevundimonas'' spp: Emerging global opportunistic pathogens. ''Virulence''. 2018 Jan 1;9(1):480-493. doi: [https://doi.org/10.1080/21505594.2017.1419116 10.1080/21505594.2017.1419116]. PMID: 29484917; PMCID: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955483/ PMC5955483]. Category:Gram-negative bacilli" Tag: Visual edit
  • 12:3612:36, 8 May 2023 diff hist +712 N CD markersCreated page with "{| class="wikitable sortable" !CD !Specific Cells Identified |- |CD1 |T cells (all) |- |CD3 |T cells (mature) |- |CD4 |T cells (helper) |- |CD8 |T cells (cytotoxic) |- |CD10 |B cells (developing) |- |CD13 |granulocytes and monocytes |- |CD14 |monocytes |- |CD15 |granulocytes |- |CD16 |NK cells |- |CD19 |B cells (developing and mature) |- |CD20 |B cells (developing and mature) |- |CD21 |B cells (mature) |- |CD23 |B cells (mature) |- |CD33 |myeloid precursors and monocytes..." Tag: Visual edit

7 May 2023

6 May 2023

5 May 2023

4 May 2023

2 May 2023

1 May 2023

30 April 2023

29 April 2023

20 April 2023

17 April 2023

14 April 2023

12 April 2023

11 April 2023

10 April 2023

1 April 2023

29 March 2023

  • 22:3922:39, 29 March 2023 diff hist +91 Program evaluationNo edit summary current Tag: Visual edit
  • 22:3922:39, 29 March 2023 diff hist +3,381 N Program evaluationCreated page with "== Ten Steps == * Clarify what is to be evaluated: you need a clearly-defined goal or goals, population, strategies, activities, outputs, and outcomes * Engage stakeholders, to build support * Assess resources and evaluability ** Is it clear why you are doing an evaluation? ** Will it be useful? ** Is there buy-in from leadership? ** Are adequate resources available? ** Is the timing right? * Determine your evaluation questions, involving as many stakeholders as possibl..." Tag: Visual edit

27 March 2023

23 March 2023

16 March 2023

13 March 2023

12 March 2023

10 March 2023

9 March 2023

8 March 2023

7 March 2023

6 March 2023

3 March 2023

2 March 2023

1 March 2023

28 February 2023

24 February 2023

21 February 2023

20 February 2023

18 February 2023

15 February 2023

10 February 2023

9 February 2023

8 February 2023

6 February 2023

31 January 2023

27 January 2023

24 January 2023

23 January 2023

20 January 2023

19 January 2023

18 January 2023

16 January 2023

12 January 2023

11 January 2023

9 January 2023

8 January 2023

7 January 2023

4 January 2023

27 December 2022

23 December 2022

21 December 2022

20 December 2022

16 December 2022

15 December 2022

14 December 2022

13 December 2022

9 December 2022

  • 18:3418:34, 9 December 2022 diff hist +299 Pyoderma gangrenosumNo edit summary Tag: Visual edit
  • 18:2618:26, 9 December 2022 diff hist +1,239 N Pyoderma gangrenosumCreated page with "== Diagnosis == === Diagnostic Criteria<ref>Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: [https://doi.org/10.1001/jamadermatol.2017.5980 10.1001/jamadermatol.2017.5980..." Tag: Visual edit

8 December 2022

5 December 2022

30 November 2022

27 November 2022

24 November 2022

23 November 2022

22 November 2022

21 November 2022

18 November 2022

17 November 2022

16 November 2022

15 November 2022

14 November 2022

13 November 2022

11 November 2022

10 November 2022

9 November 2022

8 November 2022

7 November 2022

6 November 2022

5 November 2022

4 November 2022

2 November 2022

1 November 2022

  • 13:3413:34, 1 November 2022 diff hist +1,030 N Granulomatous diseaseCreated page with "== Background == * Granulomatous inflammation is chronic inflammation that involves macrophages and T lymphocytes to wall off an infectious organism * T cells are activated and in turn activate macrophages, which undergo morphological changes to become more epithelioid * Creates two main types of granulomas: foreign body granulomas, and immune ganulomas ** In immune granulomas, macrophages active T cells to produce IL-2 == Differential Diagnosis == * Tuberculosis..." Tag: Visual edit

29 October 2022

27 October 2022

26 October 2022

22 October 2022

20 October 2022

19 October 2022

18 October 2022

17 October 2022

16 October 2022

15 October 2022

13 October 2022

12 October 2022

11 October 2022

9 October 2022

6 October 2022

3 October 2022

2 October 2022

1 October 2022

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)